Marinus Pharmaceuticals, Inc., a clinical-stage pharmaceutical company, is focused on developing and commercializing therapies to treat rare seizure disorders. Its clinical-stage product candidate, ganaxolone, is an allosteric modulator of GABAA, developed in formulations for two routes, including intravenous (IV) and oral for adult and pediatric patient populations in acute and chronic care, and settings. hospital and self-administered. . The company’s product candidate ganaxolone acts at synaptic and extrasynaptic GABAA receptors, a target for its anticonvulsant, antidepressant and anxiolytic potential. It is developing ganaxolone for status epilepticus, cyclin-like 5-dependent kinase deficiency disorder, PCDH19-related epilepsy, tuberous sclerosis complex and postpartum depression. Marinus Pharmaceuticals, Inc.
How to buy shares of Marinus Pharmaceuticals (MRNS) | Walkthrough in Spanish
Do you want to learn how to buy Marinus Pharmaceuticals (MRNS) shares on Nasdaq safely and through a regulated broker? Do you like the fact of being able to invest your profits from the piggy bank and obtain profits in the stock market? In this tutorial I am going to show you how you can invest in DEGIRO , a reliable investment broker with very low commissions, and how you are going to be able to obtain your first shares of the company Marinus Pharmaceuticals, Inc. (MRNS) (MRNS) easily. fast and intuitive.
The procedure is easy to follow :
- First, we will create a degiro account, a platform in which we will invest in the shares of Marinus Pharmaceuticals, Inc. (MRNS) with the ticker (MRNS).
- Next we will deposit funds and execute our 1st investment in the stock market.
- As soon as we have the funds we have to search for Marinus Pharmaceuticals using the TICKER, which is MRNS.
- To finish, we are only going to indicate the number of shares we want, the purchase price and the type of order.
It may be that the step by step has been somewhat simple for you, therefore I am going to summarize the purchase process with images.
How to register in degiro.
As a first step we must register in degiro with this link :
It will require an e-mail, a username and a pin code to access, and then we will continue with the link that has been sent to us by email address.
DEGIRO will immediately require some data of interest to be able to certify our identity . We must have in hand the passport number, national identity document or driving document, your cell phone and the number of the bank account that we are going to use to make our first deposit. If you do not understand what this format is, you can review this simple guide article that we have made at Educacep .
Once our account is accepted we will be able to pay money from the Deposit/Withdraw tab. We have the possibility of proceeding to make a bank transfer that will take between two to three days, or carry out the deposit quickly using Sofort, a truly secure and reliable payment gateway.
How to buy Marinus Pharmaceuticals (MRNS) shares through DeGiro
As long as we have the capital we will have the possibility of buying our 1st share. You can select the Place Order button that is located in a corner or select the DeGiro search engine and type the ticker. In the following screenshot you will find that I have written the Amazon Ticker but you have to enter (MRNS), the Marinus Pharmaceuticals ticker. Since we are talking about an action, we will see that the related results are listed and there we will discover to find Marinus Pharmaceuticals. The essential thing is that the ticker, the name of the action and the market in which it is listed coincide. Amazon is listed on NASDAQ (NDQ) and in your case Marinus Pharmaceuticals, Inc. (MRNS) is listed on Nasdaq. This step is essential so do not get confused.
At the time of placing the order we will have to be attentive to the following . We can proceed to place a limit or market order. You think you want to buy a share of Marinus Pharmaceuticals at 16.78, but its true price is quite prominent. With a limit order we are going to put the value at which we want to execute the acquisition and until there are no shares for sale at a certain value, the purchase operation of the share will not be carried out. With a market order, you will buy the number of shares that we have indicated at the currently selling price, which will be very much in line with the live listing price.
In all cases it is essential that you look at the type of position: permanent or day . As an example, in Spain, the stock market price is from tomorrow until 1:00 p.m., and in the United States it coincides with the afternoon schedule in Spain. If an order is fixed, it will continue until the moment it gets executed, but if you select the «of the day» option, at the moment the trading day ends, if it has not been executed, it will be deleted from your tab in Activity – Orders in pending status.
I would like this short text to be useful to you to buy shares in Marinus Pharmaceuticals. THANK YOU.
|Name||Title||Payment||exercised||Year of birth|
|Scott N. Braunstein, MD||CEO, President and Director||898.88k||N/A||1963|
|Mr. Edward F. Smith CPA||Consultant||570.09k||N/A||1971|
|Dr Joseph Hulihan MD||Medical director||488.87k||N/A||1956|
|Mr. Steven E. Pfanstiel CMA, MBA||CFO and Treasurer||N/A||N/A||1973|
|Ms Sasha Damouni Ellis||Vice President of Investor Relations and Corporate Communications||N/A||N/A||N/A|
|Mrs. Martha E. Manning||Vice President, General Counsel and Sec.||N/A||N/A||1955|
|Mr. Thomas J. Lyons||Vice President of Corp., Bus. Devel. and business planning||N/A||N/A||N/A|
|Mrs. Lisa Lejuwaan||Vice President of Sales||N/A||N/A||N/A|
|Mrs Rose McKinley||Vice President of HR and Organizational Development.||N/A||N/A||N/A|
|Dr Alex Aimetti||Head of Scientific Affairs||N/A||N/A||N/A|
Recent Marinus Pharmaceuticals Events:
Recent Events September 23, 2020 Dividend Date July 10, 2020 Full Filed 8-K: Subscription to a Definitive Material Agreement, Termination of a Material June 17, 2020 Full Filed 8-K: Changes in Registrant Accountant , Financial Statements as of May 29, 2020 Completely filed 8-K: Execution of a final material agreement, financial statements and May 27, 2020 Completely Filed 8-K: Submission of matters to the vote of security holders, Other events, Fi